Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles matching "europe"

PolicyPUBMEDApr 1

Patient partnership model in rare and complex rheumatological conditions: research and beyond in European Reference Network ReCONNET.

A European network for rare connective tissue diseases has created a new model where patients are treated as equal partners in research and care decisions. Instead of doctors alone deciding what to study and how to treat patients, this network includes patients in every step—from identifying problems to writing research papers together. This approach helps address long diagnostic delays and gaps in care that patients with these rare diseases often face.

WHY IT MATTERSPatients with rare connective tissue diseases can now directly influence research priorities and treatment approaches through structured partnership roles, rather than having decisions made without their input.
💬 Ask your doctorrare connective tissue diseasessystemic sclerosissystemic lupus erythematosusRead →
PolicyPUBMEDMar 26

Health Technology Assessment Guidelines and Recommendations Across European Union Countries and the United Kingdom in Rare Disease and Paediatric Populations.

European countries are updating their rules for deciding whether new medicines work well and are worth the cost, especially for rare diseases and children. Because rare diseases affect few people and there's less testing data available, countries are making special adjustments to their evaluation methods. This study looked at how 28 European countries and the UK are handling these evaluations differently.

WHY IT MATTERSIf your country updates its health technology assessment rules, it could affect how quickly new rare disease treatments get approved and whether your insurance will cover them.
Good to knowrare diseasespediatric diseasesRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases